SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-14-052298
Filing Date
2014-08-25
Accepted
2014-08-25 16:26:06
Documents
9
Period of Report
2014-08-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v387677_8-k.htm 8-K 23925
2 EXHIBIT 4.1 v387677_ex4-1.htm EX-4.1 758819
3 EXHIBIT 10.1 v387677_ex10-1.htm EX-10.1 118237
4 GRAPHIC tpg76.jpg GRAPHIC 3267
5 GRAPHIC tpg77.jpg GRAPHIC 3926
6 GRAPHIC tpg78.jpg GRAPHIC 4123
7 GRAPHIC tpg79.jpg GRAPHIC 3956
8 GRAPHIC tpg81.jpg GRAPHIC 3505
9 GRAPHIC tpg82.jpg GRAPHIC 5598
  Complete submission text file 0001144204-14-052298.txt   936638
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35737 | Film No.: 141062815
SIC: 2834 Pharmaceutical Preparations